默克

最新新闻

• Morgan Stanley Maintains Merck & Co(MRK.US) With Buy Rating, Cuts Target Price to $177
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 评级变动
  Morgan Stanley Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $179
  \u5e02\u573a\u8d44\u8baf · 2026/9/21
• 公司公告
  MRK Holdings: Marco Co., Ltd. has obtained certification as a "Gender‑Friendly Plus" business operator in Osaka Prefecture.
  JPX · 2026/9/11
• 评级变动
  BofA Securities Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $166
  \u5e02\u573a\u8d44\u8baf · 2026/9/23
• BMO Capital Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $170
  \u5e02\u573a\u8d44\u8baf · 2026/10/8
• UBS Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $175
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 公司公告
  MRK Holdings: Notice: "A Musical Hour for Adults," hosted by MISEL Co., Ltd.
  JPX · 2026/7/10
• 评级变动
  TD Cowen Maintains Merck & Co(MRK.US) With Hold Rating, Raises Target Price to $155
  \u5e02\u573a\u8d44\u8baf · 2026/9/23
• 公司公告
  MRK Holdings: Notice of the "Live Entertainment Show ~You & I~" hosted by MISEL Co., Ltd.
  JPX · 2026/7/10
• Cantor Fitzgerald Maintains Merck & Co(MRK.US) With Hold Rating, Raises Target Price to $145
  \u5e02\u573a\u8d44\u8baf · 2026/10/8
• 评级变动
  J.P. Morgan Maintains Merck & Co(MRK.US) With Buy Rating, Announces Target Price $165
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  Scotiabank Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $180
  \u5e02\u573a\u8d44\u8baf · 2026/9/29
• BofA Securities Maintains Merck & Co(MRK.US) With Buy Rating, Cuts Target Price to $163
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 公司公告
  MRK Holdings: Notice of Corporate Logo Change for MRK Holdings Co., Ltd.
  JPX · 2026/10/1
• 评级变动
  Scotiabank Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $155
  \u5e02\u573a\u8d44\u8baf · 2026/9/23
• 评级变动
  RBC Capital Maintains Merck & Co(MRK.US) With Hold Rating, Maintains Target Price $150
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 公司公告
  MRK Holdings: Matters concerning controlling shareholders, etc.
  JPX · 2026/6/15
• 评级变动
  Goldman Sachs Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $160
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME) and Merck & Company (MRK)
  TipRanks · 2026/9/25
• 评级变动
  DBS Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $180
  \u5e02\u573a\u8d44\u8baf · 2026/9/12
• 评级变动
  Leerink Partners Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $161
  \u5e02\u573a\u8d44\u8baf · 2026/9/10
• 评级变动
  Barclays Downgrades Merck & Co(MRK.US) to Hold Rating, Raises Target Price to $174.46
  \u5e02\u573a\u8d44\u8baf · 2026/9/8
• 评级变动
  Guggenheim Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $170
  \u5e02\u573a\u8d44\u8baf · 2026/9/8
• UBS Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $175
  \u5e02\u573a\u8d44\u8baf · 2026/9/24
• BMO Capital Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $170
  \u5e02\u573a\u8d44\u8baf · 2026/9/25

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。